ClinicalTrials.gg
RecruitingNCT04973397VALIANCEUpdated Nov 4, 2026

Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study

An observational study in Preoperative Care, Surgery--Complications and Myocardial Infarction, sponsored by Centre hospitalier de l'Université de Montréal (CHUM). Recruiting at 16 sites in 4 countries. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Centre hospitalier de l'Université de Montréal (CHUM) · Observational

How we know

From the registry’s dates

  • Started Nov 2021; still recruiting 5 years later.
Updated Nov 4, 2026Site recruiting status changedStudy contact changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
15,000
Ages
45 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 171 studies in Myocardial Infarction with a site in Canada — 18 open to participants now, 30 under way, 9 of them phase 3. Myocardial Infarction · Canada.

Planned enrollment
7th of 36
15,000 · median 1,060
Started
2021
with 7 others
Observational
36 of 171
6 open now
Primary completion
2026-12
later than 13 of 29 live
Registered
149th of 171
by date

Among the 171 studies in Myocardial Infarction with a site in Canada, this one is the 7th largest by planned enrollment of the 36 observational ones that give a count, is one of 8 that started in 2021, is one of 36 observational ones, reaches primary completion later than 13 of the 29 other live ones, and was the 149th registered.

Myocardial Infarction

2,273 studies on the registry are indexed under Myocardial Infarction; 373 are open to participants now.

Browse Myocardial Infarction studies →

Open to participants now

18 of the 171 studies in Myocardial Infarction with a site in Canada are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 256 Myocardial Infarction studies recruiting now, 173 (68%) set no upper age limit and 25 (10%) stop at 75 or younger; 17 take children under 18; 27 take healthy volunteers.

This study: 45 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 171 studies in Myocardial Infarction with a site in Canada, or all of them as a file.
02

Study summary

The proportion of noncardiac surgeries performed as same-day surgery is increasing worldwide, with more complex surgeries being performed on higher risk patients in the outpatient setting. Little is known on the risk factors, incidence and prognosis of patients undergoing same-day noncardiac surgery. The main objective of this study is to inform on the incidence and risk factors of cardiovascular and other adverse events after same-day surgery and to develop risk prediction tools to better inform on the risk and selection of patients undergoing same-day surgery.

Read the detailed description

The VALIANCE Study is a 15,000 patient, multicentre, prospective observational cohort of adults undergoing elective same-day noncardiac surgery and who will be followed for 90 days after surgery. The primary objective of the study is to determine the incidence of major cardiovascular complications after same-day surgery. Patients will also be followed for the occurence of other adverse postoperative complications and determine their change in quality of life at 90 days after surgery. VALIANCE will inform on the risk factors for postoperative complications and allow to develop risk prediction tools to guide patient selection and risk stratification of patients undergoing same-day surgery. The study will also look at validating the use of the Duke Activity Status Index questionnaire, Clinical Frailty Scale, and the Revised Cardiac Risk Index. Postoperative pain will be evaluated using the Brief pain inventory score and quality of life using the EQ-5D-5L questionnaire.

03

Conditions studied

  • Preoperative Care
  • Surgery--Complications
  • Myocardial Infarction

Keywords

  • Preoperative Care
  • Surgery
  • Postoperative complications
  • Same-day surgery
  • Ambulatory surgery
  • Outpatient surgery
04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All eligible adults undergoing elective same-day noncardiac surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 45-64 years of age with at least one risk factor, or ≥65 years of age;
  • undergoing elective noncardiac same-day surgery;
  • planned duration in the operating room 60 minutes or more;
  • provided written consent.

Exclusion criteria

Exclusion Criteria:

  • intervention does not require the presence of an anesthesiologist;
  • procedure is performed by a nonsurgical specialty (e.g., gastroenterology, pneumology, radio-oncology or radiology);
  • intervention is an ophthalmologic procedure;
  • previously enrolled in the VALIANCE study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
15,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Unplanned healthcare utilization

    the number of patients who have at least one of the following: unplanned admission after surgery, unplanned outpatient visit, emergency room visit and rehospitalization after same-day surgery

    Time frame: 90 days

Secondary outcomes

  1. unplanned admission

    the number of patients who have to be admitted to the hospital after undergoing a surgery planned as same-day

    Time frame: 90 days

  2. unplanned outpatient visit

    the number of patient who had a medical visit in an outpatient setting after undergoing same-day surgery

    Time frame: 90 days

  3. emergency room visit

    the number of patients who visited the emergency room without subsequent hospitalization after undergoing same-day surgery

    Time frame: 90 days

  4. re-hospitalization

    the number of patients who have to be readmitted to the hospital after being discharged home following their same-day surgery

    Time frame: 90 days

  5. major cardiovascular complications

    the number of patients who have at least one of the following: myocardial injury or infarction, non-fatal cardiac arrest, coronary revascularization, stroke, transient ischemic attack, new clinically significant arrythmia, congestive heart failure, unplanned postoperative admission for vascular reasons, emergency room visit for vascular reasons, rehospitalization for vascular reasons, and all-cause mortality

    Time frame: 90 days

  6. myocardial injury after noncardiac surgery (MINS)

    the number of patients who experience a MINS

    Time frame: 90 days

  7. myocardial infarction

    the number of patients who experience a myocardial infarction

    Time frame: 90 days

  8. non-fatal cardiac arrest

    the number of patients who experience a non-fatal cardiac arrest

    Time frame: 90 days

  9. coronary revascularization

    the number of patients who undergo coronary revascularization

    Time frame: 90 days

  10. stroke

    the number of patients who experience a stroke

    Time frame: 90 days

  11. transient ischemic attack

    the number of patients who experience a transient ischemic attack

    Time frame: 90 days

  12. new clinically important arrythmia

    the number of patients who experience a new clinically important arrythmia

    Time frame: 90 days

  13. acute congestive heart failure

    the number of patients who experience an acute congestive heart failure episode

    Time frame: 90 days

  14. deep vein thrombosis

    the number of patients who experience a deep vein thrombosis

    Time frame: 90 days

  15. pulmonary embolism

    the number of patients who experience a pulmonary embolism

    Time frame: 90 days

  16. major postoperative and life-threatening bleeding

    the number of patients who experience a major postoperative and/or life-threatening bleeding

    Time frame: 90 days

  17. postoperative infection

    the number of patients who experience a postoperative infection

    Time frame: 90 days

  18. acute kidney injury

    the number of patients who experience a acute kidney injury

    Time frame: 90 days

  19. quality of life score on the 5-level EQ-5D version (EQ-5D-5L) questionnaire

    score on the EQ-5D-5L questionnaire on 4 health profiles (level 1 to 5), overall self-rated health status (0-100 visual analogue scale), and EQ-5D-5L index value (0.01-0.99)

    Time frame: 90 days

  20. functional capacity score on the Duke Activity Status Index (DASI)

    change in the score on the Duke Activity Status Index (DASI) questionnaire (0 to 58.2 points)

    Time frame: 90 days

  21. frailty

    change in the level on the Clinical Frailty Scale (level 1 to 9)

    Time frame: 90 days

07

Study locations

11 of 16 sites recruiting
08

References and documents

Publications

  • Boko MF, Khanna AK, D'Aragon F, Spence J, Conen D, Patel A, Ayad S, Wijeysundera DN, Choiniere M, Sessler DI, Carrier FM, Harlock J, Koopman JSHA, Durand M, Bhojani N, Turan A, Page G, Devereaux PJ, Duceppe E; VALIANCE Study Collaborators. Incidence and Risk Factors of Chronic Postoperative Pain in Same-day Surgery: A Prospective Cohort Study. Anesthesiology. 2024 Aug 1;141(2):286-299. doi: 10.1097/ALN.0000000000005030. PubMed 38669010 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2021 (actual). Primary completion is estimated for Dec 2026, 61 months after the start.

Of 298 non-industry observational studies under Myocardial Infarction, half reached primary completion within 55 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 140. This study's planned 61 months is above that.

Counting every sponsor, half of 335 studies reached it within 48 months; a quarter within 18 and three quarters within 114.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 13, 2021
First posted
Jul 22, 2021
StartActual
Nov 17, 2021
Primary completionEst.
Dec 2026
CompletionEst.
Apr 2027
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
3 sites changed recruiting status (3 now active, not recruiting)
Show 3 sites
  • Cleveland Clinic Foundation Main Campus · Cleveland, United StatesRecruiting→Active, not recruiting
  • McMaster University Medical Centre · Hamilton, CanadaRecruiting→Active, not recruiting
  • St-Micheal's Hospital · Toronto, CanadaRecruiting→Active, not recruiting
Nov 4, 2026
Contact
Study contact's phone or email changed: m•••@ssss.gouv.qc.ca→v•••@ssss.gouv.qc.ca. See the current contact
Nov 4, 2026
Site contacts
Changed at 3 sites. See the sites
Show 3 sites
  • Cleveland Clinic Foundation Main Campus · Cleveland, United StatesContact removed (no phone or email listed)
  • McMaster University Medical Centre · Hamilton, CanadaContact removed (no phone or email listed)
  • St-Micheal's Hospital · Toronto, CanadaContact removed (no phone or email listed)
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    3 sites changed recruiting status (3 now active, not recruiting)
    Show 3 sites
    • Cleveland Clinic Foundation Main Campus · Cleveland, United StatesRecruiting→Active, not recruiting
    • McMaster University Medical Centre · Hamilton, CanadaRecruiting→Active, not recruiting
    • St-Micheal's Hospital · Toronto, CanadaRecruiting→Active, not recruiting
    Contact Study contact's phone or email changed: m•••@ssss.gouv.qc.ca→v•••@ssss.gouv.qc.ca. See the current contact
    Site contacts Changed at 3 sites. See the sites
    Show 3 sites
    • Cleveland Clinic Foundation Main Campus · Cleveland, United StatesContact removed (no phone or email listed)
    • McMaster University Medical Centre · Hamilton, CanadaContact removed (no phone or email listed)
    • St-Micheal's Hospital · Toronto, CanadaContact removed (no phone or email listed)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04973397
Collaborators
Canadian Institutes of Health Research (CIHR), Université de Montréal, Fonds de la Recherche en Santé du Québec
Responsible party
Sponsor
First posted
Jul 22, 2021
Start date
Nov 17, 2021
Primary completion
Dec 2026 (estimated)
Completion
Apr 2027 (estimated)
Last update
Nov 4, 2026

Study contacts

Melodie Fanay Boko, MSc
Contact
valiance.chum@ssss.gouv.qc.ca
514-890-8000 ext. 31541
Emmanuelle Duceppe, MD, PhD
principal investigator · Centre hospitalier de l'Université de Montréal (CHUM)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion